MIRM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.87%

Insider Buying (Last 12 Months): $115,064.40

Insider Selling (Last 12 Months): $1,657,025.44

Mirum Pharmaceuticals Insider Trading History Chart

Mirum Pharmaceuticals Share Price & Price History

^$41.51

▲ +0.38 (0.92%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.

Mirum Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/14/2024	Jolanda Howe	SVP	Sell	2,500	$47.10	$117,750.00	2,426
9/18/2024	Patrick J Heron	Director	Buy	115	$37.40	$4,301.00	162,308
9/6/2024	Patrick J Heron	Director	Buy	230	$41.58	$9,563.40	162,193
7/2/2024	Jolanda Howe	SVP	Sell	375	$34.00	$12,750.00	2,426
6/24/2024	Pamela Vig	Insider	Sell	30,559	$34.00	$1,039,006.00	27,406
6/5/2024	Saira Ramasastry	Director	Sell	5,000	$25.68	$128,400.00
3/27/2024	Eric Bjerkholt	CFO	Buy	2,000	$24.80	$49,600.00	14,000
3/25/2024	Peter Radovich	COO	Sell	4,303	$25.80	$111,017.40	29,013
3/18/2024	Eric Bjerkholt	CFO	Buy	2,000	$25.80	$51,600.00	12,000
2/2/2024	Jolanda Howe	SVP	Sell	735	$26.19	$19,249.65	1,759
1/8/2024	Christopher Peetz	CEO	Sell	5,209	$28.03	$146,008.27	110,125
1/8/2024	Jolanda Howe	SVP	Sell	528	$28.04	$14,805.12	722
1/8/2024	Lara Longpre	Insider	Sell	1,019	$28.04	$28,572.76	105,254
1/8/2024	Peter Radovich	COO	Sell	1,408	$28.03	$39,466.24	36,485
12/5/2023	Jolanda Howe	SVP	Sell	2,500	$32.40	$81,000.00
9/14/2023	Michael G. Grey	Director	Sell	14,216	$32.00	$454,912.00
9/11/2023	Eric Bjerkholt	CFO	Buy	10,000	$29.65	$296,500.00	10,000
9/11/2023	Patrick J Heron	Director	Buy	4,687	$30.30	$142,016.10	152,678
8/31/2023	Patrick J Heron	Director	Buy	147,991	$26.25	$3,884,763.75	147,991
8/25/2023	Jolanda Howe	SVP	Sell	3,459	$26.23	$90,729.57
7/3/2023	Christopher Peetz	CEO	Sell	5,498	$25.65	$141,023.70	115,334
7/3/2023	Jolanda Howe	SVP	Sell	915	$25.65	$23,469.75	3,459
7/3/2023	Lara Longpre	Insider	Sell	1,004	$25.65	$25,752.60	105,839
7/3/2023	Peter Radovich	COO	Sell	1,425	$25.65	$36,551.25	37,675
5/3/2023	Michael G. Grey	Director	Sell	14,608	$28.00	$409,024.00
11/14/2022	Niall O'donnell	Director	Sell	32,109	$19.60	$629,336.40	1,714,888
11/11/2022	Niall O'donnell	Director	Sell	174,121	$19.99	$3,480,678.79	1,746,997
6/6/2022	James E Flynn	Major Shareholder	Sell	38,478	$25.01	$962,334.78	1,540,190

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

SEC Filings (Institutional Ownership Changes) for Mirum Pharmaceuticals (NASDAQ:MIRM)

Institutional Buying and Selling by Quarter

Mirum Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/13/2024	Lord Abbett & CO. LLC	741,368	$28.91M	0.1%	N/A	1.544%
11/16/2024	Geode Capital Management LLC	936,197	$36.52M	0.0%	+3.2%	1.950%
11/15/2024	Frazier Life Sciences Management L.P.	6,570,392	$256.25M	10.3%	+1.2%	13.687%
11/15/2024	Barclays PLC	245,918	$9.59M	0.0%	+4.6%	0.512%
11/15/2024	Y Intercept Hong Kong Ltd	5,516	$0.22M	0.0%	N/A	0.011%
11/15/2024	Wellington Management Group LLP	122,334	$4.77M	0.0%	+62.2%	0.255%
11/15/2024	State Street Corp	1,793,728	$69.96M	0.0%	+19.9%	3.737%
11/15/2024	Janus Henderson Group PLC	4,480,284	$174.74M	0.1%	-10.2%	9.333%
11/15/2024	HighVista Strategies LLC	13,571	$0.53M	0.2%	-32.8%	0.028%
11/15/2024	Erste Asset Management GmbH	260,000	$10.14M	0.1%	N/A	0.545%
11/14/2024	PDT Partners LLC	113,712	$4.44M	0.4%	+188.9%	0.238%
11/14/2024	Eventide Asset Management LLC	3,445,363	$134.37M	2.3%	-24.5%	7.221%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	63,461	$2.48M	0.0%	+5.7%	0.133%
11/14/2024	FORA Capital LLC	10,226	$0.40M	0.0%	N/A	0.021%
11/13/2024	Loomis Sayles & Co. L P	499,316	$19.47M	0.0%	N/A	1.047%
11/12/2024	Charles Schwab Investment Management Inc.	328,161	$12.80M	0.0%	+5.5%	0.688%
11/12/2024	HealthInvest Partners AB	138,321	$5.40M	2.5%	+83.9%	0.290%
11/9/2024	Intech Investment Management LLC	12,733	$0.50M	0.0%	N/A	0.027%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	67,375	$2.63M	0.0%	+46.9%	0.141%
11/8/2024	Phocas Financial Corp.	37,889	$1.48M	0.0%	-37.3%	0.079%
11/7/2024	First Turn Management LLC	647,611	$25.26M	4.0%	-7.9%	1.357%
11/5/2024	GSA Capital Partners LLP	57,985	$2.26M	0.2%	+791.7%	0.122%
10/30/2024	AlphaCentric Advisors LLC	45,000	$1.76M	1.3%	-29.7%	0.094%
10/28/2024	Rice Hall James & Associates LLC	242,711	$9.47M	0.5%	+5.7%	0.515%
10/25/2024	Golden State Equity Partners	19,380	$0.76M	0.2%	-2.8%	0.041%
10/25/2024	China Universal Asset Management Co. Ltd.	9,176	$0.36M	0.0%	+65.7%	0.019%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	1,725	$67K	0.0%	+22.6%	0.004%
10/23/2024	Values First Advisors Inc.	23,725	$0.93M	0.5%	+20.1%	0.050%
10/23/2024	Hennion & Walsh Asset Management Inc.	116,054	$4.53M	0.2%	+10.8%	0.246%
10/18/2024	Raymond James & Associates	137,628	$5.37M	0.0%	-4.6%	0.292%
10/16/2024	Secure Asset Management LLC	36,514	$1.42M	0.2%	-20.5%	0.077%
10/11/2024	Creative Planning	6,382	$0.25M	0.0%	N/A	0.013%
8/27/2024	Clearbridge Investments LLC	699,933	$23.93M	0.0%	+165.5%	1.485%
8/15/2024	The Manufacturers Life Insurance Company	22,134	$0.76M	0.0%	-49.9%	0.047%
8/15/2024	Millennium Management LLC	265,443	$9.08M	0.0%	-50.8%	0.563%
8/15/2024	AQR Capital Management LLC	8,294	$0.28M	0.0%	-74.1%	0.018%
8/15/2024	AXA S.A.	425,992	$14.57M	0.0%	-28.3%	0.904%
8/15/2024	Affinity Asset Advisors LLC	155,000	$5.30M	0.6%	-3.1%	0.329%
8/14/2024	Squarepoint Ops LLC	67,421	$2.31M	0.0%	+63.4%	0.143%
8/14/2024	Marshall Wace LLP	20,520	$0.70M	0.0%	+35.9%	0.044%
8/14/2024	ProShare Advisors LLC	6,224	$0.21M	0.0%	N/A	0.013%
8/14/2024	Profund Advisors LLC	13,008	$0.45M	0.0%	-68.2%	0.028%
8/12/2024	XTX Topco Ltd	15,245	$0.52M	0.0%	N/A	0.032%
8/12/2024	Amalgamated Bank	1,357	$46K	0.0%	+60.8%	0.003%
8/8/2024	William Blair Investment Management LLC	677,939	$23.18M	0.1%	+8.1%	1.438%
8/8/2024	Federated Hermes Inc.	5,400	$0.19M	0.0%	-40.0%	0.011%
8/8/2024	First Turn Management LLC	703,398	$24.05M	3.9%	-26.6%	1.492%
8/8/2024	Ground Swell Capital LLC	10,780	$0.37M	0.3%	N/A	0.023%
8/8/2024	Rice Hall James & Associates LLC	229,730	$7.85M	0.5%	+6.9%	0.487%
8/6/2024	Quest Partners LLC	1,142	$39K	0.0%	+7,513.3%	0.002%
8/6/2024	Candriam S.C.A.	508,475	$17.38M	0.1%	N/A	1.079%
8/5/2024	Arizona State Retirement System	9,210	$0.32M	0.0%	+10.6%	0.020%
8/1/2024	Rhumbline Advisers	52,916	$1.81M	0.0%	+48.5%	0.112%
7/31/2024	Commonwealth Equity Services LLC	14,050	$0.48M	0.0%	+17.1%	0.030%
7/29/2024	Principal Financial Group Inc.	7,001	$0.24M	0.0%	-15.9%	0.015%
7/26/2024	Bank of New York Mellon Corp	143,000	$4.89M	0.0%	+48.2%	0.303%
7/26/2024	AlphaCentric Advisors LLC	64,000	$2.19M	1.6%	-31.9%	0.136%
7/24/2024	Secure Asset Management LLC	45,904	$1.57M	0.3%	+8.6%	0.097%
7/20/2024	Hennion & Walsh Asset Management Inc.	104,770	$3.58M	0.2%	+64.9%	0.222%
7/19/2024	Raymond James & Associates	144,214	$4.93M	0.0%	+10.5%	0.306%
7/19/2024	Values First Advisors Inc.	19,754	$0.68M	0.4%	-7.7%	0.042%
7/16/2024	Wealth Enhancement Advisory Services LLC	16,409	$0.56M	0.0%	-47.9%	0.035%
5/16/2024	California State Teachers Retirement System	86,992	$2.19M	0.0%	-58.8%	0.185%
5/16/2024	Janus Henderson Group PLC	2,767,210	$69.47M	0.0%	+34.2%	5.871%
5/16/2024	Silvercrest Asset Management Group LLC	162,817	$4.09M	0.0%	+64.6%	0.345%
5/15/2024	Price T Rowe Associates Inc. MD	1,597,506	$40.13M	0.0%	+37.2%	3.390%
5/15/2024	Affinity Asset Advisors LLC	160,000	$4.02M	0.5%	+220.0%	0.339%
5/13/2024	Clearbridge Investments LLC	263,584	$6.62M	0.0%	-0.2%	0.559%
5/10/2024	Vanguard Group Inc.	2,211,685	$55.56M	0.0%	-10.7%	4.694%
5/8/2024	William Blair Investment Management LLC	627,272	$15.76M	0.0%	+0.9%	1.331%
5/8/2024	Russell Investments Group Ltd.	17,481	$0.44M	0.0%	+11.7%	0.037%
5/1/2024	Janney Montgomery Scott LLC	14,812	$0.37M	0.0%	-38.5%	0.031%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	18,641	$0.45M	0.0%	+7.2%	0.040%
4/30/2024	Allspring Global Investments Holdings LLC	18,455	$0.46M	0.0%	-20.0%	0.039%
4/29/2024	China Universal Asset Management Co. Ltd.	8,952	$0.23M	0.0%	+66.0%	0.019%
4/23/2024	Wetzel Investment Advisors Inc.	2,400	$57K	0.0%	+71.4%	0.005%
4/23/2024	Rice Hall James & Associates LLC	214,887	$5.40M	0.3%	+401.6%	0.457%
4/23/2024	Raymond James Financial Services Advisors Inc.	97,891	$2.46M	0.0%	+63.0%	0.208%
4/18/2024	Allspring Global Investments Holdings LLC	18,455	$0.46M	0.0%	-20.0%	0.039%
4/17/2024	Hennion & Walsh Asset Management Inc.	63,534	$1.60M	0.1%	+31.0%	0.135%
4/16/2024	Wealth Enhancement Advisory Services LLC	31,489	$0.79M	0.0%	-2.7%	0.067%
4/5/2024	Los Angeles Capital Management LLC	41,836	$1.05M	0.0%	+10.8%	0.089%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	211,949	$6.26M	0.0%	+111.9%	0.451%
2/26/2024	Virtu Financial LLC	6,881	$0.20M	0.0%	-18.5%	0.015%
2/26/2024	Perceptive Advisors LLC	534,942	$15.79M	0.4%	-20.4%	1.148%
2/20/2024	Eventide Asset Management LLC	2,663,649	$78.63M	1.3%	-32.7%	5.715%
2/15/2024	Octagon Capital Advisors LP	25,000	$0.74M	0.1%	N/A	0.054%
2/15/2024	Frazier Life Sciences Management L.P.	6,495,392	$191.74M	10.3%	+0.4%	13.934%
2/15/2024	Boone Capital Management LLC	490,139	$14.47M	3.4%	+25.7%	1.051%
2/14/2024	Cadian Capital Management LP	1,934,922	$57.12M	2.3%	+34.8%	4.151%
2/14/2024	Partners Group Holding AG	18,271	$0.54M	0.1%	N/A	0.039%
2/14/2024	StepStone Group LP	4,568	$0.14M	0.0%	N/A	0.010%
2/14/2024	CenterBook Partners LP	51,837	$1.53M	0.2%	+242.4%	0.111%
2/13/2024	Affinity Asset Advisors LLC	50,000	$1.48M	0.3%	+66.7%	0.107%
2/13/2024	Rafferty Asset Management LLC	130,346	$3.85M	0.0%	-5.0%	0.280%
2/13/2024	NEOS Investment Management LLC	7,442	$0.22M	0.0%	N/A	0.016%
2/13/2024	California State Teachers Retirement System	211,111	$6.23M	0.0%	+672.9%	0.453%
2/12/2024	TD Asset Management Inc	47,000	$1.39M	0.0%	N/A	0.101%
2/12/2024	Steward Partners Investment Advisory LLC	39,550	$1.17M	0.0%	+31.6%	0.085%
2/9/2024	Franklin Resources Inc.	913,068	$26.95M	0.0%	+22.6%	1.959%

Data available starting January 2016

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is approved as treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for adjunctive treatment of patients with peroxisomal disorders, including peroxisome biogenesis disorder-Zellweger spectrum disorder and Smith-Lemli-Opitz syndrome; and Chenodal, a tablet, which is approved for the treatment of radiolucent stones in the gallbladder, and under Phase 3 development for the treatment cerebrotendinous xanthomatosis. In addition, it develops Volixibat, an oral and minimally absorbed agent designed to inhibit IBAT, currently under Phase 2b clinical trial for the treatment of adult patients with cholestatic liver diseases. The company was incorporated in 2018 and is headquartered in Foster City, California.

Today's Range

Now: $41.51

$40.58

$42.85

50 Day Range

MA: $42.18

$38.42

$46.65

52 Week Range

Now: $41.51

$23.14

$48.89

Volume

1,185,007 shs

Average Volume

546,433 shs

Market Capitalization

$1.99 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Mirum Pharmaceuticals?: Mirum Pharmaceuticals' top insider investors include:
Patrick J Heron (Director)
Christopher Peetz (CEO)
Lara Longpre (Insider)
Peter Radovich (COO)
Pamela Vig (Insider)
Eric Bjerkholt (CFO)
Jolanda Howe (SVP)
Michael G Grey (Director)
Saira Ramasastry (Director)
Learn More about top insider investors at Mirum Pharmaceuticals.
Who are the major institutional investors of Mirum Pharmaceuticals?: Mirum Pharmaceuticals' top institutional investors include:
Frazier Life Sciences Management L.P. — 13.69%
Janus Henderson Group PLC — 9.33%
Eventide Asset Management LLC — 7.22%
State Street Corp — 3.74%
Geode Capital Management LLC — 1.95%
Lord Abbett & CO. LLC — 1.54%
Learn More about top institutional investors of Mirum Pharmaceuticals stock.
Which institutional investors are selling Mirum Pharmaceuticals stock?: During the last quarter, MIRM stock was sold by these institutional investors:
Eventide Asset Management LLC
Janus Henderson Group PLC
First Turn Management LLC
Phocas Financial Corp.
AlphaCentric Advisors LLC
Secure Asset Management LLC
HighVista Strategies LLC
Raymond James & Associates
Within the last year, company insiders that have sold Mirum Pharmaceuticals company stock include:
Patrick J Heron (Director)
Christopher Peetz (CEO)
Lara Longpre (Insider)
Peter Radovich (COO)
Pamela Vig (Insider)
Eric Bjerkholt (CFO)
Learn More investors selling Mirum Pharmaceuticals stock.
Which institutional investors are buying Mirum Pharmaceuticals stock?: In the last quarter, MIRM stock was bought by institutional investors including:
Lord Abbett & CO. LLC
Loomis Sayles & Co. L P
State Street Corp
Erste Asset Management GmbH
Jane Street Group LLC
Frazier Life Sciences Management L.P.
PDT Partners LLC
HealthInvest Partners AB
Within the last year, these company insiders have bought Mirum Pharmaceuticals stock:
Patrick J Heron (Director)
Christopher Peetz (CEO)
Learn More investors buying Mirum Pharmaceuticals stock.